IP Library › Granted Patent US 7,972,855
Granted Patent B2
US 7,972,855 · App. 11/607,032 · Granted Jul 5, 2011

Microorganisms that extracellularly secrete lipids and methods of producing lipid and lipid vesicles encapsulating lipids using said microorganisms

Assignee: Suntory Holdings Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,972,855
App. No.
11/607,032
Granted
Jul 5, 2011
Kind
B2
Abstract

There are provided microorganisms, for example, Mortierella alpina , having a property of producing a lipid containing unsaturated fatty acids as constituent fatty acids and extracellularly secreting the produced lipid encapsulated in lipid vesicles, methods of screening said microorganisms, as well as methods of efficiently producing a fatty acid-containing lipid using said microorganisms. Furthermore, there are provided lipid vesicles encapsulating a lipid containing unsaturated fatty acids, and foods, cosmetics, and animal feeds comprising said lipid vesicles added thereto. Artificially treated microorganisms or microorganisms collected from nature are grown on a solid medium, and microbial strains that form lipid vesicles at the periphery of the colonies and/or microbial strains that, when cultured in a transparent liquid medium, make the culture liquid cloudy are selected. The microorganisms obtained are cultured, lipid-containing lipid vesicles secreted in the culture liquid, are separated from the culture liquid, and the lipid is separated and purified.

Claims (18)

1. A method of screening a strain of microorganism which extracellularly secretes an unsaturated fatty acid-containing lipid, comprising artificially treating a microorganism with a mutagenic agent or under a mutagenic condition, wherein the microorganism to be treated accumulates the unsaturated fatty acid-containing lipid in the cell, culturing the treated microorganism on a solid medium, and identifying a colony of the treated microorganism which is covered with lipid-containing vesicles at the periphery.

2. A method of screening a strain of microorganism which extracellularly secretes an unsaturated fatty acid-containing lipid, comprising artificially treating a microorganism with a mutagenic agent or under a mutagenic condition, wherein the microorganism to be treated accumulates the unsaturated fatty acid-containing lipid in the cell, culturing the treated microorganism on a solid medium, selecting a colony that is covered with lipid-containing lipid vesicles at the periphery, culturing the selected colony in a transparent liquid medium, and identifying a colony that produces a cloudy culture liquid.

3. A method of screening a strain of microorganism which extracellularly secretes an unsaturated fatty acid-containing lipid, comprising: artificially treating a microorganism with a mutagenic agent or under a mutagenic condition, wherein the microorganism to be treated accumulates the unsaturated fatty acid-containing lipid in the cell, culturing the treated microorganism on a solid medium, and selecting a colony covered with lipid-containing lipid vesicles at the periphery.

4. A screening method for identifying a microorganism that extracellularly secretes a lipid containing unsaturated fatty acids comprising: artificially treating a microorganism with a mutagenic agent or under a mutagenic condition, wherein the microorganism to be treated accumulates the unsaturated fatty acid-containing lipid in the cell,

culturing the treated microorganism on a solid medium,

selecting a colony covered with lipid-containing vesicles at the periphery,

culturing the selected microorganism in a transparent liquid medium, and

determining whether the culture liquid becomes cloudy.

5. The method of claim 1 , wherein said artificial treating step comprises mutagen treatment, gene manipulation, or cell fusion.

6. The method of claim 1 , wherein said artificial treating step comprises treating the microorganism with N-methyl-N′-nitro-N-nitrosoguanidine (NGT).

7. The method of claim 2 , wherein said artificial treating step comprises mutagen treatment.

8. The method of claim 2 , wherein said artificial treating step comprises treating the microorganism with N-methyl-N′-nitro-N-nitrosoguanidine (NGT).

9. The method of any of claims 1 , 2 , or 3 , wherein the microorganism is of the genus Mortierella.

10. The method of claim 9 , wherein the Mortierella microorganism is Mortierella alpina.

11. The method of claim 4 , wherein said unsaturated fatty acids have 18 carbons and three or more double bonds, or 20 or more carbons and two or more double bonds.

12. The method of claim 4 , wherein said microorganism is a filamentous fungus.

13. The method of claim 4 , wherein the microorganism is selected from genus Mortierella.

14. The method of claim 13 , wherein the microorganism is Mortierella alpina.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 27, 2009
From: SUNTORY LIMITED
To: SUNTORY HOLDINGS LIMITED
Reel/Frame 023049/0707 →
Priority Claims (1)
JP 11-229509 · Aug 13, 1999 · national
Continuity (2)
Division 09807541
Related Publication 20070077638A1 · Apr 5, 2007